Current clinical applications of in vivo gene therapy with AAVs
JR Mendell, SA Al-Zaidy, LR Rodino-Klapac… - Molecular Therapy, 2021 - cell.com
Hereditary diseases are caused by mutations in genes, and more than 7,000 rare diseases
affect over 30 million Americans. For more than 30 years, hundreds of researchers have …
affect over 30 million Americans. For more than 30 years, hundreds of researchers have …
The genetic basis of phenotypic heterogeneity in the neuronal ceroid lipofuscinoses
The neuronal ceroid lipofuscinoses (NCLs) are a group of inherited neurodegenerative
disorders that affect children and adults. They share some similar clinical features and the …
disorders that affect children and adults. They share some similar clinical features and the …
CLN3 is required for the clearance of glycerophosphodiesters from lysosomes
Lysosomes have many roles, including degrading macromolecules and signalling to the
nucleus. Lysosomal dysfunction occurs in various human conditions, such as common …
nucleus. Lysosomal dysfunction occurs in various human conditions, such as common …
Impairment of lysosome function and autophagy in rare neurodegenerative diseases
F Darios, G Stevanin - Journal of molecular biology, 2020 - Elsevier
Rare genetic diseases affect a limited number of patients, but their etiology is often known,
facilitating the development of reliable animal models and giving the opportunity to …
facilitating the development of reliable animal models and giving the opportunity to …
Altered protein secretion in Batten disease
RJ Huber - Disease Models & Mechanisms, 2021 - journals.biologists.com
The neuronal ceroid lipofuscinoses (NCLs), collectively known as Batten disease, are a
group of neurological diseases that affect all ages and ethnicities worldwide. There are 13 …
group of neurological diseases that affect all ages and ethnicities worldwide. There are 13 …
[HTML][HTML] Heterozygous GBA D409V and ATP13a2 mutations do not exacerbate pathological α-synuclein spread in the prodromal preformed fibrils model in young …
ME Johnson, L Bergkvist, L Stetzik, JA Steiner… - Neurobiology of …, 2021 - Elsevier
Autophagic dysregulation and lysosomal impairment have been implicated in the
pathogenesis of Parkinson's disease, partly due to the identification of mutations in multiple …
pathogenesis of Parkinson's disease, partly due to the identification of mutations in multiple …
Neuronal progenitor cells-based metabolomics study reveals dysregulated lipid metabolism and identifies putative biomarkers for CLN6 disease
CM Rus, DL Polla, S Di Bucchianico, S Fischer… - Scientific Reports, 2023 - nature.com
Abstract Neuronal ceroid lipofuscinosis 6 (CLN6) is a rare and fatal autosomal recessive
disease primarily affecting the nervous system in children. It is caused by a pathogenic …
disease primarily affecting the nervous system in children. It is caused by a pathogenic …
CLN5 and CLN3 function as a complex to regulate endolysosome function
S Yasa, E Sauvageau, G Modica… - Biochemical …, 2021 - portlandpress.com
CLN5 is a soluble endolysosomal protein whose function is poorly understood. Mutations in
this protein cause a rare neurodegenerative disease, neuronal ceroid lipofuscinosis (NCL) …
this protein cause a rare neurodegenerative disease, neuronal ceroid lipofuscinosis (NCL) …
Converging roles of PSENEN/PEN2 and CLN3 in the autophagy-lysosome system
M Klein, A Kaleem, S Oetjen, D Wünkhaus, L Binkle… - Autophagy, 2022 - Taylor & Francis
ABSTRACT PSENEN/PEN2 is the smallest subunit of the γ-secretase complex, an
intramembrane protease that cleaves proteins within their transmembrane domains …
intramembrane protease that cleaves proteins within their transmembrane domains …
Recent insights into the networking of CLN genes and proteins in mammalian cells
RJ Huber - Journal of Neurochemistry, 2023 - Wiley Online Library
Ceroid lipofuscinosis neuronal (CLN) genes encode 13 proteins that localize throughout the
endomembrane system to regulate a variety of cellular processes. In humans, mutations in …
endomembrane system to regulate a variety of cellular processes. In humans, mutations in …